Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1998 Jun;64(6):742–746. doi: 10.1136/jnnp.64.6.742

Longitudinal SPECT study in Alzheimer's disease: relation to apolipoprotein E polymorphism

M Lehtovirta 1, J Kuikka 1, S Helisalmi 1, P Hartikainen 1, A Mannermaa 1, M Ryynanen 1, P Riekkinen 1, H Soininen 1
PMCID: PMC2170126  PMID: 9647302

Abstract

OBJECTIVES—In mild Alzheimer's disease, SPECT imaging of regional cerebral blood flow has highlighted deficits in the posterior association cortex, and later in the disease process, the deficit spreads to involve the frontal cortex. The ε4 allele of apolipoprotein E is a risk factor for Alzheimer's disease. The effect of apolipoprotein E polymorphism on cerebral perfusion was studied. The hypothesis was that those patients with Alzheimer's disease who carry the ε4 allele would have more severe cerebral hypoperfusion.
METHODS—Thirty one patients with Alzheimer's disease and eight age and sex matched control subjects were examined in a three year longitudinal study. Patients with Alzheimer's disease were divided into subgroups according to their number of ε4 alleles. Regional cerebral blood flow ratios referred to the cerebellum were examined by 99mTc-HMPAO SPECT. Apolipoprotein E genotypes were determined by digestion of polymerase chain reaction products with the restriction enzyme Hha1.
RESULTS—All patients with Alzheimer's disease had bilateral temporoparietal hypoperfusion compared with control subjects. The two ε4 allele subgroups had the lowest ratios at the baseline assessment in the parietal and occipital cortices, and at the follow up in the temporal, parietal, and occipital cortices. They had the highest reduction in percentage terms in the temporal and occipital cortices compared with the other subgroups. However, the global clinical severity did not differ at the baseline or follow up examinations between the subgroups.
CONCLUSION—Apolipoprotein E polymorphism is involved in the pathogenesis and heterogeneity of Alzheimer's disease as the most severe cerebral hypoperfusion was found in the ε4 allele subgroups. This might have implications for therapeutic approaches in Alzheimer's disease.



Full Text

The Full Text of this article is available as a PDF (139.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albin R. L., Minoshima S., D'Amato C. J., Frey K. A., Kuhl D. A., Sima A. A. Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology. 1996 Aug;47(2):462–466. doi: 10.1212/wnl.47.2.462. [DOI] [PubMed] [Google Scholar]
  2. Bondi M. W., Salmon D. P., Monsch A. U., Galasko D., Butters N., Klauber M. R., Thal L. J., Saitoh T. Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults. Neurology. 1995 Dec;45(12):2203–2206. doi: 10.1212/wnl.45.12.2203. [DOI] [PubMed] [Google Scholar]
  3. Brown D. R., Hunter R., Wyper D. J., Patterson J., Kelly R. C., Montaldi D., McCullouch J. Longitudinal changes in cognitive function and regional cerebral function in Alzheimer's disease: a SPECT blood flow study. J Psychiatr Res. 1996 Mar-Apr;30(2):109–126. doi: 10.1016/0022-3956(95)00032-1. [DOI] [PubMed] [Google Scholar]
  4. Brun A., Englund E. Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading. Histopathology. 1981 Sep;5(5):549–564. doi: 10.1111/j.1365-2559.1981.tb01818.x. [DOI] [PubMed] [Google Scholar]
  5. Burns A., Philpot M. P., Costa D. C., Ell P. J., Levy R. The investigation of Alzheimer's disease with single photon emission tomography. J Neurol Neurosurg Psychiatry. 1989 Feb;52(2):248–253. doi: 10.1136/jnnp.52.2.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993 Aug 13;261(5123):921–923. doi: 10.1126/science.8346443. [DOI] [PubMed] [Google Scholar]
  7. Eberling J. L., Jagust W. J., Reed B. R., Baker M. G. Reduced temporal lobe blood flow in Alzheimer's disease. Neurobiol Aging. 1992 Jul-Aug;13(4):483–491. doi: 10.1016/0197-4580(92)90076-a. [DOI] [PubMed] [Google Scholar]
  8. Folstein M. F., Folstein S. E., McHugh P. R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  9. Frackowiak R. S., Pozzilli C., Legg N. J., Du Boulay G. H., Marshall J., Lenzi G. L., Jones T. Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain. 1981 Dec;104(Pt 4):753–778. doi: 10.1093/brain/104.4.753. [DOI] [PubMed] [Google Scholar]
  10. HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 Feb;23:56–62. doi: 10.1136/jnnp.23.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Habert M. O., Spampinato U., Mas J. L., Piketty M. L., Bourdel M. C., de Recondo J., Rondot P., Askienazy S. A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia. Eur J Nucl Med. 1991;18(1):3–11. doi: 10.1007/BF00177677. [DOI] [PubMed] [Google Scholar]
  12. Helkala E. L., Laulumaa V., Soininen H., Riekkinen P. J. Recall and recognition memory in patients with Alzheimer's and Parkinson's diseases. Ann Neurol. 1988 Aug;24(2):214–217. doi: 10.1002/ana.410240207. [DOI] [PubMed] [Google Scholar]
  13. Hixson J. E., Vernier D. T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990 Mar;31(3):545–548. [PubMed] [Google Scholar]
  14. Johnson K. A., Mueller S. T., Walshe T. M., English R. J., Holman B. L. Cerebral perfusion imaging in Alzheimer's disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123. Arch Neurol. 1987 Feb;44(2):165–168. doi: 10.1001/archneur.1987.00520140035014. [DOI] [PubMed] [Google Scholar]
  15. Kuikka J. T., Tenhunen-Eskelinen M., Jurvelin J., Kiiliänen H. Physical performance of the Siemens MultiSPECT 3 gamma camera. Nucl Med Commun. 1993 Jun;14(6):490–497. doi: 10.1097/00006231-199306000-00013. [DOI] [PubMed] [Google Scholar]
  16. Lehtovirta M., Helisalmi S., Mannermaa A., Soininen H., Koivisto K., Ryynänen M., Riekkinen P., Sr Apolipoprotein E polymorphism and Alzheimer's disease in eastern Finland. Neurosci Lett. 1995 Feb 6;185(1):13–15. doi: 10.1016/0304-3940(94)11213-3. [DOI] [PubMed] [Google Scholar]
  17. Lehtovirta M., Laakso M. P., Soininen H., Helisalmi S., Mannermaa A., Helkala E. L., Partanen K., Ryynänen M., Vainio P., Hartikainen P. Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience. 1995 Jul;67(1):65–72. doi: 10.1016/0306-4522(95)00014-a. [DOI] [PubMed] [Google Scholar]
  18. Liu H. C., Liu R. S., Lin K. N., Wang S. J., Fuh J. L., Yeh S. H., Chiang B. N. Single photon emission computed tomography using 99Tcm-HMPAO in Alzheimer's disease. Nucl Med Commun. 1992 Jul;13(7):535–541. doi: 10.1097/00006231-199207000-00009. [DOI] [PubMed] [Google Scholar]
  19. Mayeux R., Stern Y., Ottman R., Tatemichi T. K., Tang M. X., Maestre G., Ngai C., Tycko B., Ginsberg H. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann Neurol. 1993 Nov;34(5):752–754. doi: 10.1002/ana.410340527. [DOI] [PubMed] [Google Scholar]
  20. Mayeux R., Stern Y., Spanton S. Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology. 1985 Apr;35(4):453–461. doi: 10.1212/wnl.35.4.453. [DOI] [PubMed] [Google Scholar]
  21. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939–944. doi: 10.1212/wnl.34.7.939. [DOI] [PubMed] [Google Scholar]
  22. Najlerahim A., Bowen D. M. Biochemical measurements in Alzheimer's disease reveal a necessity for improved neuroimaging techniques to study metabolism. Biochem J. 1988 Apr 1;251(1):305–308. doi: 10.1042/bj2510305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. O'Brien J. T., Eagger S., Syed G. M., Sahakian B. J., Levy R. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1992 Dec;55(12):1182–1187. doi: 10.1136/jnnp.55.12.1182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Perani D., Di Piero V., Vallar G., Cappa S., Messa C., Bottini G., Berti A., Passafiume D., Scarlato G., Gerundini P. Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease. J Nucl Med. 1988 Sep;29(9):1507–1514. [PubMed] [Google Scholar]
  25. Perry E. K., Haroutunian V., Davis K. L., Levy R., Lantos P., Eagger S., Honavar M., Dean A., Griffiths M., McKeith I. G. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuroreport. 1994 Mar 21;5(7):747–749. doi: 10.1097/00001756-199403000-00002. [DOI] [PubMed] [Google Scholar]
  26. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 1994 Dec;17(12):525–530. doi: 10.1016/0166-2236(94)90156-2. [DOI] [PubMed] [Google Scholar]
  27. Reed T., Carmelli D., Swan G. E., Breitner J. C., Welsh K. A., Jarvik G. P., Deeb S., Auwerx J. Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele. Arch Neurol. 1994 Dec;51(12):1189–1192. doi: 10.1001/archneur.1994.00540240033012. [DOI] [PubMed] [Google Scholar]
  28. Reiman E. M., Caselli R. J., Yun L. S., Chen K., Bandy D., Minoshima S., Thibodeau S. N., Osborne D. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med. 1996 Mar 21;334(12):752–758. doi: 10.1056/NEJM199603213341202. [DOI] [PubMed] [Google Scholar]
  29. Rosen W. G., Terry R. D., Fuld P. A., Katzman R., Peck A. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol. 1980 May;7(5):486–488. doi: 10.1002/ana.410070516. [DOI] [PubMed] [Google Scholar]
  30. Rossor M. N., Iversen L. L., Reynolds G. P., Mountjoy C. Q., Roth M. Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br Med J (Clin Res Ed) 1984 Mar 31;288(6422):961–964. doi: 10.1136/bmj.288.6422.961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Rossor M. N. Molecular pathology of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1993 Jun;56(6):583–586. doi: 10.1136/jnnp.56.6.583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sandbrink R., Hartmann T., Masters C. L., Beyreuther K. Genes contributing to Alzheimer's disease. Mol Psychiatry. 1996 Mar;1(1):27–40. [PubMed] [Google Scholar]
  33. Sato A., Sato Y. Regulation of regional cerebral blood flow by cholinergic fibers originating in the basal forebrain. Neurosci Res. 1992 Sep;14(4):242–274. doi: 10.1016/0168-0102(92)90071-j. [DOI] [PubMed] [Google Scholar]
  34. Saunders A. M., Strittmatter W. J., Schmechel D., George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-MacLachlan D. R., Alberts M. J. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993 Aug;43(8):1467–1472. doi: 10.1212/wnl.43.8.1467. [DOI] [PubMed] [Google Scholar]
  35. Small G. W., Mazziotta J. C., Collins M. T., Baxter L. R., Phelps M. E., Mandelkern M. A., Kaplan A., La Rue A., Adamson C. F., Chang L. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA. 1995 Mar 22;273(12):942–947. [PubMed] [Google Scholar]
  36. Soininen H. S., Partanen K., Pitkänen A., Vainio P., Hänninen T., Hallikainen M., Koivisto K., Riekkinen P. J., Sr Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: correlation to visual and verbal memory. Neurology. 1994 Sep;44(9):1660–1668. doi: 10.1212/wnl.44.9.1660. [DOI] [PubMed] [Google Scholar]
  37. Soininen H., Helkala E. L., Kuikka J., Hartikainen P., Lehtovirta M., Riekkinen P. J., Sr Regional cerebral blood flow measured by 99mTc-HMPAO SPECT differs in subgroups of Alzheimer's disease. J Neural Transm Park Dis Dement Sect. 1995;9(2-3):95–109. doi: 10.1007/BF02259652. [DOI] [PubMed] [Google Scholar]
  38. Soininen H., Kosunen O., Helisalmi S., Mannermaa A., Paljärvi L., Talasniemi S., Ryynänen M., Riekkinen P., Sr A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele. Neurosci Lett. 1995 Mar 3;187(2):79–82. doi: 10.1016/0304-3940(95)11343-6. [DOI] [PubMed] [Google Scholar]
  39. Strittmatter W. J., Weisgraber K. H., Goedert M., Saunders A. M., Huang D., Corder E. H., Dong L. M., Jakes R., Alberts M. J., Gilbert J. R. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol. 1994 Feb;125(2):163–174. doi: 10.1006/exnr.1994.1019. [DOI] [PubMed] [Google Scholar]
  40. Tsukamoto K., Watanabe T., Matsushima T., Kinoshita M., Kato H., Hashimoto Y., Kurokawa K., Teramoto T. Determination by PCR-RFLP of apo E genotype in a Japanese population. J Lab Clin Med. 1993 Apr;121(4):598–602. [PubMed] [Google Scholar]
  41. Webster D. D. Critical analysis of the disability in Parkinson's disease. Mod Treat. 1968 Mar;5(2):257–282. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES